| Literature DB >> 25970247 |
Yi-Gang Tong1, Wei-Feng Shi2, Di Liu3, Jun Qian4, Long Liang1, Xiao-Chen Bo5, Jun Liu6, Hong-Guang Ren1, Hang Fan1, Ming Ni5, Yang Sun4, Yuan Jin1, Yue Teng1, Zhen Li5, David Kargbo7, Foday Dafae7, Alex Kanu8, Cheng-Chao Chen9, Zhi-Heng Lan9, Hui Jiang9, Yang Luo10, Hui-Jun Lu4, Xiao-Guang Zhang6, Fan Yang11, Yi Hu1, Yu-Xi Cao6, Yong-Qiang Deng1, Hao-Xiang Su11, Yu Sun1, Wen-Sen Liu4, Zhuang Wang1, Cheng-Yu Wang4, Zhao-Yang Bu4, Zhen-Dong Guo4, Liu-Bo Zhang12, Wei-Min Nie13, Chang-Qing Bai14, Chun-Hua Sun1, Xiao-Ping An1, Pei-Song Xu5, Xiang-Li-Lan Zhang1, Yong Huang1, Zhi-Qiang Mi1, Dong Yu1, Hong-Wu Yao1, Yong Feng15, Zhi-Ping Xia4, Xue-Xing Zheng4, Song-Tao Yang4, Bing Lu1, Jia-Fu Jiang1, Brima Kargbo7, Fu-Chu He16, George F Gao17, Wu-Chun Cao1.
Abstract
A novel Ebola virus (EBOV) first identified in March 2014 has infected more than 25,000 people in West Africa, resulting in more than 10,000 deaths. Preliminary analyses of genome sequences of 81 EBOV collected from March to June 2014 from Guinea and Sierra Leone suggest that the 2014 EBOV originated from an independent transmission event from its natural reservoir followed by sustained human-to-human infections. It has been reported that the EBOV genome variation might have an effect on the efficacy of sequence-based virus detection and candidate therapeutics. However, only limited viral information has been available since July 2014, when the outbreak entered a rapid growth phase. Here we describe 175 full-length EBOV genome sequences from five severely stricken districts in Sierra Leone from 28 September to 11 November 2014. We found that the 2014 EBOV has become more phylogenetically and genetically diverse from July to November 2014, characterized by the emergence of multiple novel lineages. The substitution rate for the 2014 EBOV was estimated to be 1.23 × 10(-3) substitutions per site per year (95% highest posterior density interval, 1.04 × 10(-3) to 1.41 × 10(-3) substitutions per site per year), approximating to that observed between previous EBOV outbreaks. The sharp increase in genetic diversity of the 2014 EBOV warrants extensive EBOV surveillance in Sierra Leone, Guinea and Liberia to better understand the viral evolution and transmission dynamics of the ongoing outbreak. These data will facilitate the international efforts to develop vaccines and therapeutics.Entities:
Mesh:
Year: 2015 PMID: 25970247 DOI: 10.1038/nature14490
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962